286 related articles for article (PubMed ID: 8225204)
1. Effect of aminohydroxypropylidene diphosphonate on the bone metabolism of patients with parathyroid adenoma.
Ishimura E; Miki T; Koyama H; Harada K; Nakatsuka K; Inaba M; Nishizawa Y; Morii H
Horm Metab Res; 1993 Sep; 25(9):493-7. PubMed ID: 8225204
[TBL] [Abstract][Full Text] [Related]
2. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
3. Alterations in serum and urine parameters reflecting bone turnover in uremic patients during treatment with 1,25-dihydroxyvitamin D3 and 24,25-dihydroxyvitamin D3.
Mortensen BM; Gordeladze JO; Lyngdal PT; Aarseth HP; Gautvik KM
Miner Electrolyte Metab; 1993; 19(2):78-85. PubMed ID: 8377728
[TBL] [Abstract][Full Text] [Related]
4. Changes of bone markers during long-term intravenous calcitriol therapy in maintenance dialysis patients.
Lee SH; Huang TS; Hsieh SJ
Miner Electrolyte Metab; 1996; 22(4):219-23. PubMed ID: 8807625
[TBL] [Abstract][Full Text] [Related]
5. Effect of a single infusion of aminohydroxypropylidene on calcium and bone metabolism in healthy volunteers monitored during 2 months.
Netelenbos JC; van Ginkel FC; Lips P; Leeuwenkamp OR; Barto R; van der Vijgh WJ; van der Wiel H; Hackeng WH
J Clin Endocrinol Metab; 1991 Jan; 72(1):223-8. PubMed ID: 1986022
[TBL] [Abstract][Full Text] [Related]
6. [Clinico-biochemical parallels in diverse forms of primary hyperparathyroidism].
Fekson EG; Tishenina RS; Podobedova LI
Klin Med (Mosk); 1989 Sep; 67(9):92-6. PubMed ID: 2586052
[TBL] [Abstract][Full Text] [Related]
7. [A case of esophageal carcinoma with hypercalcemia caused by PTH-rP--the effect of therapy on the bone and calcium metabolism].
Nakayama Y; Okuno S; Miki T; Nishizawa Y; Morii H
Nihon Naibunpi Gakkai Zasshi; 1992 Dec; 68(12):1294-9. PubMed ID: 1291340
[TBL] [Abstract][Full Text] [Related]
8. Clinical profile of 128 subjects operated for primary hyperparathyroidism.
Haddock L; Aguiló F; Vázquez Quintana E; Vázquez MC; Rabell V; Allende M
P R Health Sci J; 1998 Dec; 17(4):309-16. PubMed ID: 10028537
[TBL] [Abstract][Full Text] [Related]
9. Long-term elevation of 1,25-dihydroxyvitamin D after short-term intravenous administration of pamidronate (aminohydroxypropylidene bisphosphonate, APD) in Paget's disease of bone.
Devlin RD; Retallack RW; Fenton AJ; Grill V; Gutteridge DH; Kent GN; Prince RL; Worth GK
J Bone Miner Res; 1994 Jan; 9(1):81-5. PubMed ID: 8154313
[TBL] [Abstract][Full Text] [Related]
10. Patients with elevated serum parathyroid hormone levels after parathyroidectomy: showing signs of decreased peripheral parathyroid hormone sensitivity.
Nordenström E; Westerdahl J; Isaksson A; Lindblom P; Bergenfelz A
World J Surg; 2003 Feb; 27(2):212-5. PubMed ID: 12616439
[TBL] [Abstract][Full Text] [Related]
11. Phosphate depletion in the rat: effect of bisphosphonates and the calcemic response to PTH.
Jara A; Lee E; Stauber D; Moatamed F; Felsenfeld AJ; Kleeman CR
Kidney Int; 1999 Apr; 55(4):1434-43. PubMed ID: 10201008
[TBL] [Abstract][Full Text] [Related]
12. Effects of 22-oxacalcitriol and calcitriol on PTH secretion and bone mineral metabolism in a crossover trial in hemodialysis patients with secondary hyperparathyroidism.
Ogata H; Koiwa F; Shishido K; Takahashi K; Ito H; Kinugasa E; Taguchi S
Ther Apher Dial; 2007 Jun; 11(3):202-9. PubMed ID: 17498002
[TBL] [Abstract][Full Text] [Related]
13. Daily follow-up of serum parathyroid hormone and calcium after surgery for primary hyperparathyroidism.
Debruyne F; Delaere P; Ostyn F; Van den Bruel A; Bouillon R
J Otolaryngol; 1999 Dec; 28(6):305-8. PubMed ID: 10604157
[TBL] [Abstract][Full Text] [Related]
14. Severe vitamin D deficiency in a case of primary hyperparathyroidism caused by parathyroid lipoadenoma, effect of 25OHD3 treatment.
Coen G; Bondatti F; de Matteis A; Ballanti P; Mazzaferro S; Sardella D; Smacchi A
Miner Electrolyte Metab; 1989; 15(6):332-7. PubMed ID: 2615720
[TBL] [Abstract][Full Text] [Related]
15. Vitamin D metabolites and calcium absorption in severe vitamin D deficiency.
Need AG; O'Loughlin PD; Morris HA; Coates PS; Horowitz M; Nordin BE
J Bone Miner Res; 2008 Nov; 23(11):1859-63. PubMed ID: 18597633
[TBL] [Abstract][Full Text] [Related]
16. Intravenous pamidronic acid in hypercalcemia due to parathyroid carcinoma.
Vega EM; Mautalen CA
Medicina (B Aires); 1991; 51(2):106-10. PubMed ID: 1820495
[TBL] [Abstract][Full Text] [Related]
17. Effects of treatment of malignancy-associated hypercalcemia on serum parathyroid hormone-related protein.
Budayr AA; Zysset E; Jenzer A; Thiébaud D; Ammann P; Rizzoli R; Jaquet-Müller F; Bonjour JP; Gertz B; Burckhardt P
J Bone Miner Res; 1994 Apr; 9(4):521-6. PubMed ID: 8030440
[TBL] [Abstract][Full Text] [Related]
18. Markers of bone remodeling in the elderly subject: effects of vitamin D insufficiency and its correction.
Brazier M; Kamel S; Maamer M; Agbomson F; Elesper I; Garabedian M; Desmet G; Sebert JL
J Bone Miner Res; 1995 Nov; 10(11):1753-61. PubMed ID: 8592953
[TBL] [Abstract][Full Text] [Related]
19. Effects of vitamin K2 in hemodialysis patients with low serum parathyroid hormone levels.
Nakashima A; Yorioka N; Doi S; Masaki T; Ito T; Harada S
Bone; 2004 Mar; 34(3):579-83. PubMed ID: 15003806
[TBL] [Abstract][Full Text] [Related]
20. Vitamin D status, seasonal variations, parathyroid adenoma weight and bone mineral density in primary hyperparathyroidism.
Moosgaard B; Vestergaard P; Heickendorff L; Melsen F; Christiansen P; Mosekilde L
Clin Endocrinol (Oxf); 2005 Nov; 63(5):506-13. PubMed ID: 16268801
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
